Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease

Pathogenic New World orthohantaviruses cause hantavirus cardiopulmonary syndrome (HCPS), a severe immunopathogenic disease in humans manifested by pulmonary edema and respiratory distress, with case fatality rates approaching 40%. High levels of inflammatory mediators are present in the lungs and sy...

Full description

Bibliographic Details
Main Authors: Peter Simons, Yan Guo, Virginie Bondu, Susan L. Tigert, Michelle Harkins, Samuel Goodfellow, Cana Tompkins, Devon Chabot-Richards, Xuexian O. Yang, Laura Gonzalez Bosc, Steven Bradfute, Daniel A. Lawrence, Tione Buranda
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/8/1597
id doaj-9ad3a7db571d4e9080ad245888970e02
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Peter Simons
Yan Guo
Virginie Bondu
Susan L. Tigert
Michelle Harkins
Samuel Goodfellow
Cana Tompkins
Devon Chabot-Richards
Xuexian O. Yang
Laura Gonzalez Bosc
Steven Bradfute
Daniel A. Lawrence
Tione Buranda
spellingShingle Peter Simons
Yan Guo
Virginie Bondu
Susan L. Tigert
Michelle Harkins
Samuel Goodfellow
Cana Tompkins
Devon Chabot-Richards
Xuexian O. Yang
Laura Gonzalez Bosc
Steven Bradfute
Daniel A. Lawrence
Tione Buranda
Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease
Viruses
PAI-1
orthohantavirus
hantavirus
principal component analysis
plasminogen activation
cytokines
author_facet Peter Simons
Yan Guo
Virginie Bondu
Susan L. Tigert
Michelle Harkins
Samuel Goodfellow
Cana Tompkins
Devon Chabot-Richards
Xuexian O. Yang
Laura Gonzalez Bosc
Steven Bradfute
Daniel A. Lawrence
Tione Buranda
author_sort Peter Simons
title Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease
title_short Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease
title_full Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease
title_fullStr Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease
title_full_unstemmed Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease
title_sort longitudinal assessment of cytokine expression and plasminogen activation in hantavirus cardiopulmonary syndrome reveals immune regulatory dysfunction in end-stage disease
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2021-08-01
description Pathogenic New World orthohantaviruses cause hantavirus cardiopulmonary syndrome (HCPS), a severe immunopathogenic disease in humans manifested by pulmonary edema and respiratory distress, with case fatality rates approaching 40%. High levels of inflammatory mediators are present in the lungs and systemic circulation of HCPS patients. Previous studies have provided insights into the pathophysiology of HCPS. However, the longitudinal correlations of innate and adaptive immune responses and disease outcomes remain unresolved. This study analyzed serial immune responses in 13 HCPS cases due to Sin Nombre orthohantavirus (SNV), with 11 severe cases requiring extracorporeal membrane oxygenation (ECMO) treatment and two mild cases. We measured viral load, levels of various cytokines, urokinase plasminogen activator (uPA), and plasminogen activator inhibitor-1 (PAI-1). We found significantly elevated levels of proinflammatory cytokines and PAI-1 in five end-stage cases. There was no difference between the expression of active uPA in survivors’ and decedents’ cases. However, total uPA in decedents’ cases was significantly higher compared to survivors’. In some end-stage cases, uPA was refractory to PAI-1 inhibition as measured by zymography, where uPA and PAI-1 were strongly correlated to lymphocyte counts and IFN-γ. We also found bacterial co-infection influencing the etiology and outcome of immune response in two cases. Unsupervised Principal Component Analysis and hierarchical cluster analyses resolved separate waves of correlated immune mediators expressed in one case patient due to a sequential co-infection of bacteria and SNV. Overall, a robust proinflammatory immune response, characterized by an imbalance in T helper 17 (Th17) and regulatory T-cells (Treg) subsets, was correlated with dysregulated inflammation and mortality. Our sample size is small; however, the core differences correlated to survivors and end-stage HCPS are instructive.
topic PAI-1
orthohantavirus
hantavirus
principal component analysis
plasminogen activation
cytokines
url https://www.mdpi.com/1999-4915/13/8/1597
work_keys_str_mv AT petersimons longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT yanguo longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT virginiebondu longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT susanltigert longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT michelleharkins longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT samuelgoodfellow longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT canatompkins longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT devonchabotrichards longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT xuexianoyang longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT lauragonzalezbosc longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT stevenbradfute longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT danielalawrence longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
AT tioneburanda longitudinalassessmentofcytokineexpressionandplasminogenactivationinhantaviruscardiopulmonarysyndromerevealsimmuneregulatorydysfunctioninendstagedisease
_version_ 1721189385567731712
spelling doaj-9ad3a7db571d4e9080ad245888970e022021-08-26T14:27:02ZengMDPI AGViruses1999-49152021-08-01131597159710.3390/v13081597Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage DiseasePeter Simons0Yan Guo1Virginie Bondu2Susan L. Tigert3Michelle Harkins4Samuel Goodfellow5Cana Tompkins6Devon Chabot-Richards7Xuexian O. Yang8Laura Gonzalez Bosc9Steven Bradfute10Daniel A. Lawrence11Tione Buranda12Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USABioinformatics Shared Resource Center, Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USADepartment of Pathology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAClinical and Translational Science Center (CTSC), University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USADivision of Infectious Diseases, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, NM 87131, USADivision of Infectious Diseases, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, NM 87131, USADepartment of Pathology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USADepartment of Pathology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAMolecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USAVascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USADivision of Infectious Diseases, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, NM 87131, USADivision of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pathology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAPathogenic New World orthohantaviruses cause hantavirus cardiopulmonary syndrome (HCPS), a severe immunopathogenic disease in humans manifested by pulmonary edema and respiratory distress, with case fatality rates approaching 40%. High levels of inflammatory mediators are present in the lungs and systemic circulation of HCPS patients. Previous studies have provided insights into the pathophysiology of HCPS. However, the longitudinal correlations of innate and adaptive immune responses and disease outcomes remain unresolved. This study analyzed serial immune responses in 13 HCPS cases due to Sin Nombre orthohantavirus (SNV), with 11 severe cases requiring extracorporeal membrane oxygenation (ECMO) treatment and two mild cases. We measured viral load, levels of various cytokines, urokinase plasminogen activator (uPA), and plasminogen activator inhibitor-1 (PAI-1). We found significantly elevated levels of proinflammatory cytokines and PAI-1 in five end-stage cases. There was no difference between the expression of active uPA in survivors’ and decedents’ cases. However, total uPA in decedents’ cases was significantly higher compared to survivors’. In some end-stage cases, uPA was refractory to PAI-1 inhibition as measured by zymography, where uPA and PAI-1 were strongly correlated to lymphocyte counts and IFN-γ. We also found bacterial co-infection influencing the etiology and outcome of immune response in two cases. Unsupervised Principal Component Analysis and hierarchical cluster analyses resolved separate waves of correlated immune mediators expressed in one case patient due to a sequential co-infection of bacteria and SNV. Overall, a robust proinflammatory immune response, characterized by an imbalance in T helper 17 (Th17) and regulatory T-cells (Treg) subsets, was correlated with dysregulated inflammation and mortality. Our sample size is small; however, the core differences correlated to survivors and end-stage HCPS are instructive.https://www.mdpi.com/1999-4915/13/8/1597PAI-1orthohantavirushantavirusprincipal component analysisplasminogen activationcytokines